Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction
Open Access
- 1 May 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 100 (1), 55-62
- https://doi.org/10.1111/j.1476-5381.1990.tb12051.x
Abstract
1 Interactions between the effects of adenosine or 2-chloro-adenosine (CADO) and the effects of substances that interfere with the phosphoinositides/protein kinase C transducing system or with the adenylate cyclase transducing system, on endplate potentials (e.p.ps), were investigated. The preparation used was the innervated sartorius muscle of the frog in which twitches had been prevented with high magnesium concentrations. 2 The activator of protein kinase C, 4β-phorbol-12,13-diacetate (PDAc), reversibly increased the amplitude and the quantal content of e.p.ps and attenuated the inhibitory effects of adenosine and CADO on e.p.p. amplitude. The affinity of the adenosine receptor antagonist, 8-phenyltheophylline, was not modified by PDAc. 3 The phorbol ester 4α-phorbol-12,13-didecanoate, which does not activate protein kinase C, did not modify either e.p.p. amplitude or the inhibitory effect of adenosine on e.p.ps. 4 The inhibitor of protein kinase C, polymyxin B, reversibly decreased the amplitude and the quantal content of e.p.ps, prevented the enhancement caused by PDAc on e.p.p. amplitude, but did not modify the inhibitory effect of adenosine on e.p.ps. H-7, another inhibitor of protein kinases, also decreased e.p.p. amplitude but did not modify the effect of PDAc on the amplitude of e.p.ps. 5 Lithium chloride, which alters phosphoinositide signal transduction by inhibiting the breakdown of inositol phosphates, reversibly increased the amplitude and the quantal content of the e.p.ps. In the presence of adenosine or CADO the effect of lithium on e.p.p. amplitude was markedly attenuated. 6 The activator of adenylate cyclase, forskolin, reversibly increased the amplitude and the quantal content of the e.p.ps. MDL 12,330A, an inhibitor of adenylate cyclase, irreversibly decreased e.p.p. amplitude, an effect which was prevented by forskolin. Neither forskolin nor MDL 12,330A modified the inhibitory effect of adenosine on e.p.ps. 7 The results suggest that the phosphoinositides/protein kinase C transducing system, but not the adenylate cyclase transducing system, might be involved in the inhibitory effect of adenosine on neuromuscular transmission.This publication has 48 references indexed in Scilit:
- Inositol Phospholipid Metabolism During and Following Synaptic Activation: Role of AdenosineJournal of Neurochemistry, 1989
- Adenosine Inhibition of Histamine‐Stimulated Inositol Phospholipid Hydrolysis in Mouse Cerebral CortexJournal of Neurochemistry, 1988
- Calcium-mobilizing receptorsTrends in Pharmacological Sciences, 1987
- Pharmacology of the isoquinoline sulfonamide protein kinase C inhibitorsTrends in Pharmacological Sciences, 1987
- Phorbol esters: probes of protein kinase C function in the brainTrends in Neurosciences, 1987
- Activation of protein kinase C augments evoked transmitter releaseNature, 1987
- Studies and Perspectives of Protein Kinase CScience, 1986
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984
- Cobra polypeptide cytotoxin I and marine worm polypeptide cytotoxin A‐IV are potent and selective inhibitors of phospholipid‐sensitive Ca2+‐dependent protein kinaseFEBS Letters, 1983
- Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthinesLife Sciences, 1981